Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-27

Clinical Trial Update: New Mothers Alpha-Stim [NA]

View source ↗

Summary

A clinical trial (NCT04770181) evaluating New Mothers Alpha-Stim for anxiety, depression, insomnia, and sleep quality has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • New Mothers Alpha-Stim

Snippet

Sponsor: Christina Murphey, RN, PhD | Conditions: Anxiety, Depression | NA | Status: WITHDRAWN